Qtron Investments’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,390
Closed -$213K 466
2026
Q1
$213K Hold
3,390
0.03% 414
2025
Q4
$225K Hold
3,390
0.03% 418
2025
Q3
$228K Sell
3,390
-1,271
-27% -$101K 0.03% 394
2025
Q2
$407K Hold
4,661
0.05% 363
2025
Q1
$318K Sell
4,661
-5,194
-53% -$424K 0.05% 349
2024
Q4
$766K Buy
+9,855
New +$730K 0.11% 242
2024
Q3
Sell
-7,553
Closed -$856K 437
2024
Q2
$856K Buy
7,553
+1,538
+26% +$194K 0.12% 195
2024
Q1
$834K Hold
6,015
0.12% 223
2023
Q4
$746K Buy
+6,015
New +$614K 0.12% 221
2023
Q3
Sell
-3,767
Closed -$484K 413
2023
Q2
$484K Buy
3,767
+1,711
+83% +$207K 0.09% 285
2023
Q1
$239K Hold
2,056
0.05% 374
2022
Q4
$233K Buy
+2,056
New +$226K 0.05% 388
2020
Q2
Sell
-3,128
Closed -$211K 265
2020
Q1
$211K Buy
+3,128
New +$195K 0.13% 205

Other funds holding DXCM

Qtron Investments's DXCM Position: Q2 2026 in Review

Qtron Investments sold out of DexCom (DXCM) in Q2 2026, closing a stake of 3,390 shares — an estimated $213K sold.

Qtron Investments first reported a position in DXCM in Q1 2020 and held it in 13 quarters. The position peaked at $856K in Q2 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Qtron Investments reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
  • Qtron Investments sold 3,390 DexCom shares in Q2 2026, an estimated $213K.
  • Qtron Investments first reported a position in DexCom in Q1 2020 and held it in 13 quarters.
  • Qtron Investments's DexCom position peaked at $856K in Q2 2024.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Qtron Investments's 13F filing for Q2 2026, filed 13 Aug 2026.